Increases in cyclic GMP levels may not mediate relaxant effects of sodium nitroprusside, verapamil and hydralazine in rat vas deferens.
D000818:Animals; D006152:Cyclic GMP / Q000378:metabolism*; D006830:Hydralazine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism*; D009599:Nitroprusside / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D051381:Rats; D014649:Vas Deferens / Q000187:drug effects; D014700:Verapamil / Q000494:pharmacology
D009599:Nitroprusside; D010656:Phenylephrine; D006830:Hydralazine; D014700:Verapamil; D006152:Cyclic GMP